As of 2025-02-14, the EV/EBITDA ratio of Arena Pharmaceuticals Inc (ARNA) is -10.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ARNA's latest enterprise value is 5,982.02 mil USD. ARNA's TTM EBITDA according to its financial statements is -545.06 mil USD. Dividing these 2 quantities gives us the above ARNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing P/E multiples | 13.7x - 15.4x | 14.6x |
Forward P/E multiples | 18.9x - 22.0x | 20.6x |
Fair Price | (163.74) - (133.33) | (152.83) |
Upside | -263.8% - -233.3% | -252.8% |
Date | EV/EBITDA |